Swiss Pharma Company - IDEOGEN takes over Special Access Progr...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
HURDEN, Switzerland, Jan 21, 2022 /PRNewswire-AsiaNet/ -- IDEOGEN GROUP, Managed Access division, takes over Special Access Program for BELEODAQ (R) (belinostat) in Europe, Middle East, North Africa, Russia, and CIS.BELEODAQ (R) is a prescription medicine used to treat patients with a rare form of bloo...
Authors: LATEST ASIANET NEWS RELEASES